WP
Woodline Partners Portfolio holdings
AUM
$18.9B
This Quarter Return
+12.81%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$18.9B
AUM Growth
+$18.9B
(+23%)
Cap. Flow
+$2.41B
Cap. Flow
% of AUM
12.75%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
467
Reduced
193
Closed
179
Top Buys
| 1 |
Microsoft
MSFT
|
$247M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$152M |
| 3 |
Brown & Brown
BRO
|
$120M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
$113M |
| 5 |
Akero Therapeutics
AKRO
|
$106M |
Top Sells
| 1 |
Lam Research
LRCX
|
$144M |
| 2 |
MetLife
MET
|
$97.2M |
| 3 |
Travelers Companies
TRV
|
$91.9M |
| 4 |
Electronic Arts
EA
|
$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$80.3M |
Sector Composition
| 1 | Healthcare | 25.08% |
| 2 | Technology | 24.07% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
L3Harris
LHX
$51.1B
| $35.5M | 0.19% |
141,643
-92,356
| -39% | -$23.2M |
|
152
Ciena
CIEN
$13.4B
| $35.3M | 0.19% |
434,502
-380,012
| -47% | -$30.9M |
|
|
WBA
153
DELISTED
Walgreens Boots Alliance
WBA
| $35.2M | 0.19% |
3,067,542
+981,946
| +47% | +$11.3M |
|
154
Logitech
LOGI
$15.4B
| $35.1M | 0.19% |
+389,122
| New | +$35.1M |
|
155
Axsome Therapeutics
AXSM
$6.09B
| $34.6M | 0.18% |
331,131
+27,047
| +9% | +$2.82M |
|
156
Pfizer
PFE
$141B
| $34.6M | 0.18% |
1,425,670
+222,325
| +18% | +$5.39M |
|
157
NewAmsterdam Pharma
NAMS
$2.8B
| $34.4M | 0.18% |
1,897,197
-545,200
| -22% | -$9.87M |
|
158
General Motors
GM
$55B
| $34.1M | 0.18% |
693,690
+375,138
| +118% | +$18.5M |
|
159
Amdocs
DOX
$9.31B
| $34M | 0.18% |
372,374
+143,929
| +63% | +$13.1M |
|
160
Coterra Energy
CTRA
$18.4B
| $34M | 0.18% |
+1,338,042
| New | +$34M |
|
161
Regency Centers
REG
$13.1B
| $33.8M | 0.18% |
474,974
+57,340
| +14% | +$4.08M |
|
162
Bank of America
BAC
$371B
| $33.5M | 0.18% |
708,889
+149,475
| +27% | +$7.07M |
|
163
Scholar Rock
SRRK
$3.3B
| $33.5M | 0.18% |
944,432
+84,125
| +10% | +$2.98M |
|
164
HP
HPQ
$26.8B
| $33.4M | 0.18% |
+1,367,125
| New | +$33.4M |
|
|
CAI
165
Caris Life Sciences, Inc. Common Stock
CAI
$10.4B
| $33.3M | 0.18% |
+1,246,326
| New | +$33.3M |
|
166
Boston Scientific
BSX
$159B
| $33M | 0.17% |
307,663
-100,223
| -25% | -$10.8M |
|
167
McDonald's
MCD
$226B
| $32.7M | 0.17% |
112,038
+10,281
| +10% | +$3M |
|
168
Arcus Biosciences
RCUS
$1.24B
| $32.6M | 0.17% |
4,000,029
-1,127,275
| -22% | -$9.18M |
|
169
Rhythm Pharmaceuticals
RYTM
$6.75B
| $32.5M | 0.17% |
+514,381
| New | +$32.5M |
|
170
Hudbay
HBM
$4.93B
| $32.5M | 0.17% |
3,063,295
+812,870
| +36% | +$8.62M |
|
171
PACCAR
PCAR
$50.5B
| $32.5M | 0.17% |
341,735
+329,772
| +2,757% | +$31.3M |
|
|
XHR
172
Xenia Hotels & Resorts
XHR
$1.37B
| $32.4M | 0.17% |
2,579,125
+928,555
| +56% | +$11.7M |
|
173
Weyerhaeuser
WY
$17.9B
| $32.1M | 0.17% |
1,250,110
+1,025,638
| +457% | +$26.3M |
|
174
Exelixis
EXEL
$9.95B
| $31.9M | 0.17% |
724,816
-91,877
| -11% | -$4.05M |
|
175
BJ's Restaurants
BJRI
$749M
| $31.7M | 0.17% |
710,854
+300,565
| +73% | +$13.4M |
|